Cold Chain Technologies introduces KoolTemp® GTS-Rx shipping solutions

Market leader releases pre-qualified shippers specifically designed for pharmacies

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Cold Chain Technologies (CCT), the trusted worldwide provider of thermal packaging products and services is pleased to introduce KoolTemp® GTS Rx, a complete line of cost-effective shipping solutions designed to meet the transport needs of specialty pharmacies, wholesalers, and mail order pharmacies.

GTS Rx solutions provide 2°C to 8°C overnight (up to 24 hours) and .1°C to 25°C two day (up to 48 hours) protection in payload sizes that range from 1 to 23 liters.  Available in traditional EPS (Expanded Polystyrene) and KoolTemp® GreenSmart approved configurations, GTS Rx is easy to pack, utilizes a single refrigerant SKU across all sizes, is qualified for summer and winter use and available in set up and knocked down versions.

“The last mile is that crucial step that deliveries life-saving medications to the patient or provider.  This portion of distribution is subject to several competing pressures, including cost and regulatory compliance.  The GTS Rx line of pre-qualified shippers brings years of expertise allowing last mile distribution that is both compliant and cost competitive.  Utilizing molded containers and modular single SKU refrigerants available from multiple manufacturing locations throughout the US and Europe, the GTS Rx line satisfies CFO’s and Quality Directors alike,” states Jamie Chasteen, sales and product development manager of Cold Chain Technologies.

Manufactured to safeguard the delivery of high-value temperature sensitive therapies, all KoolTemp GTS Rx shipping solutions have been pre-qualified in Cold Chain Laboratories’ world class ISTA-certified and cGMP-compliant labs.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?